Spyre Therapeutics Inc. (SYRE)
NASDAQ: SYRE
· Real-Time Price · USD
17.31
-0.40 (-2.26%)
At close: Jun 13, 2025, 3:59 PM
17.29
-0.12%
After-hours: Jun 13, 2025, 05:50 PM EDT
-2.26% (1D)
| Bid | 14.5 |
| Market Cap | 1.04B |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -208.93M |
| EPS (ttm) | -3.06 |
| PE Ratio (ttm) | -5.66 |
| Forward PE | -5.36 |
| Analyst | Buy |
| Ask | 19.5 |
| Volume | 246,324 |
| Avg. Volume (20D) | 623,785 |
| Open | 17.27 |
| Previous Close | 17.71 |
| Day's Range | 17.02 - 17.64 |
| 52-Week Range | 10.91 - 40.26 |
| Beta | 2.73 |
About SYRE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SYRE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for SYRE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+9.64%
Spyre Therapeutics shares are trading higher after...
Unlock content with
Pro Subscription
7 months ago
-8.97%
Spyre Therapeutics shares are trading lower. The company announced interim Phase 1 data from its first-in-human trial of SPY001.
